Biomarkers for tyrosine kinase inhibitors in renal cell cancer

被引：0
|
作者：
Coupe, Nicholas [1 ]
Harrison, Michelle [1 ]
Chua, Wei [1 ]
de Souza, Paul [1 ,2 ]
机构：
[1] Liverpool Hosp, Dept Med Oncol, Liverpool, NSW 2170, Australia
[2] Univ Western Sydney, Sch Med CRG, Sydney, NSW, Australia
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2012年 / 1卷 / 04期
关键词：
D O I：
10.3978/j.issn.2223-4683.2012.10.01
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：216 / 222
页数：7
相关论文
共 50 条
  • [1] Tyrosine kinase inhibitors target cancer stem cells in renal cell cancer
    Czarnecka, Anna M.
    Solarek, Wojciech
    Kornakiewicz, Anna
    Szczylik, Cezary
    [J]. ONCOLOGY REPORTS, 2016, 35 (03) : 1433 - 1442
  • [2] Tyrosine kinase inhibitors in renal cell carcinoma
    Potti, A
    George, DJ
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6371S - 6376S
  • [3] SAFE USE OF TYROSINE KINASE INHIBITORS FOR RENAL CELL CANCER IN ORGAN FAILURE
    Heng, D. Y.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 24 - 24
  • [4] Focus on resistance to tyrosine kinase inhibitors in renal cancer
    Falkowski, Sabrina
    [J]. BULLETIN DU CANCER, 2018, 105 : S255 - S260
  • [5] Investigating adherence to tyrosine kinase inhibitors in renal cancer
    Angus, Fiona
    Wang, Yubo
    Rigg, Alexander
    Chen, Li-Chia
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [6] Emerging tyrosine kinase inhibitors for the treatment of renal cancer
    Iacovelli, Roberto
    Albiges, Laurence
    Escudier, Bernard
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (03) : 379 - 392
  • [7] Novel tyrosine kinase inhibitors for renal cell carcinoma
    Dorff, Tanya B.
    Pal, Sumanta K.
    Quinn, David I.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (01) : 67 - 73
  • [8] Molecular events regulating clear cell renal cell cancer resistance to tyrosine kinase inhibitors
    Czarnecka, Anna Malgorzata
    Bielecka, Zofia F.
    Kaminska, Katarzyna
    Matak, Damian
    Szymanski, Lukasz
    Khan, Mohammed Imran
    Solarek, Wojciech
    Kornakiewicz, Anna
    Maliszewska-Olejniczak, Kamila
    Szczylik, Cezary
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
    L. M. A. Aparicio
    I. P. Fernandez
    J. Cassinello
    [J]. Clinical and Translational Oncology, 2017, 19 : 1175 - 1182
  • [10] Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
    Semeniuk-Wojtas, Aleksandra
    Lubas, Arkadiusz
    Stec, Rafal
    Szczylik, Cezary
    Niemczyk, Stanislaw
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)
12345